Tizona Therapeutics, Inc.

📍 South San Francisco, United States🗓 Founded 2015👥 50 employees💰 Last funded Nov 2020
Biotechnology Research🌐 tizonatx.com
Website LinkedIn
Tizona Therapeutics, Inc., is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Founded by MPM Capital and leading scientists from Dana Farber Cancer Institute, the University of Pittsburgh, Johns Hopkins, Memorial Sloan Kettering Cancer Center, and Brigham and Women’s Hospital, Tizona’s therapies are designed to modulate the activity of immunosuppressive cells, thereby activating the body’s ability to fight cancer or preventing the immune system from attacking healthy tissues in autoimmune diseases. Our programs target the cell types and biological mechanisms responsible for immune suppression in the tumor microenvironment and for controlling self-reactivity in autoimmunity. For more information, please email info@tizonatx.com.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Tizona Therapeutics, Inc.?
Tizona Therapeutics, Inc. has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Tizona Therapeutics, Inc. last raise funding?
The most recent investment in Tizona Therapeutics, Inc. recorded on gritt.io was in November 2020.
When was Tizona Therapeutics, Inc. founded?
Tizona Therapeutics, Inc. was founded in 2015.
What industry is Tizona Therapeutics, Inc. in?
Tizona Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Tizona Therapeutics, Inc. based?
Tizona Therapeutics, Inc. is headquartered in South San Francisco, United States.